Premium
Mutation analysis of the spastin gene ( SPG4 ) in patients in Germany with autosomal dominant hereditary spastic paraplegia
Author(s) -
Sauter S.,
Miterski B.,
Klimpe S.,
Bönsch D.,
Schöls L.,
Visbeck A.,
Papke T.,
Hopf H.C.,
Engel W.,
Deufel T.,
Epplen J.T.,
Neesen J.
Publication year - 2002
Publication title -
human mutation
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.981
H-Index - 162
eISSN - 1098-1004
pISSN - 1059-7794
DOI - 10.1002/humu.10105
Subject(s) - hereditary spastic paraplegia , frameshift mutation , genetics , biology , missense mutation , mutation , nonsense mutation , genetic heterogeneity , exon , gene , phenotype
Hereditary spastic paraplegias (HSP) comprise a genetically and clinically heterogeneous group of neurodegenerative disorders characterized by progressive spasticity and hyperreflexia of the lower limbs. Autosomal dominant hereditary spastic paraplegia 4 linked to chromosome 2p (SPG4) is the most common form of autosomal dominant hereditary spastic paraplegia. It is caused by mutations in the SPG4 gene encoding spastin, a member of the AAA protein family of ATPases. In this study the spastin gene of HSP patients from 161 apparently unrelated families in Germany was analyzed. The authors identified mutations in 27 out of the 161 HSP families; 23 of these mutations have not been described before and only one mutation was found in two families. Among the detected mutations are 14 frameshift, four nonsense, and four missense mutations, one large deletion spanning several exons, as well as four mutations that affect splicing. Most of the novel mutations are located in the conserved AAA cassette‐encoding region of the spastin gene. The relative frequency of spastin gene mutations in an unselected group of German HSP patients is approximately 17%. Frameshift mutations account for the majority of SPG4 mutations in this population. The proportion of splice mutations is considerably lower than reported elsewhere. © 2002 Wiley‐Liss, Inc.